This Study Describes the Different Causes of Death in 237 FL Patients Clinical Trial
Official title:
Causes of Death in Follicular Lymphoma: a Single Center Retrospective Analysis
Background.Although the life expectancy of patients with FL has recently increased, notably since the introduction of rituximab in combination with chemotherapy, little is known regarding the precise causes of patients death. Patients and methods'. This study describes the different causes of death in FL patients among followed since 2000 at Lyon University Hospital, centre Léon Bérard and Mayo Clinic. The causes of death will be classified as related to lymphoma progression, treatment-related toxicity (including TRM and secondary myelodysplastic syndrome/acute myeloid leukemia), secondary neoplasias, or other.
| Status | Completed |
| Enrollment | 237 |
| Est. completion date | July 2016 |
| Est. primary completion date | January 2016 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - FL patients - patients recorded as deceased Exclusion Criteria: -Other diagnosis than FL |
Time Perspective: Retrospective
| Country | Name | City | State |
|---|---|---|---|
| France | Centre hospitalier Lyon sud | Pierre Bénite | Rhône Alpes |
| Lead Sponsor | Collaborator |
|---|---|
| Hospices Civils de Lyon |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | overall survival (OS) | OS length was calculated from the date of diagnosis to the date of death | No |